Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

290.33
+3.231.13%
Post-market: 291.501.17+0.40%19:40 EDT
Volume:2.00M
Turnover:580.21M
Market Cap:156.11B
PE:26.53
High:293.57
Open:289.80
Low:289.01
Close:287.10
Loading ...

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com

Dow Jones
·
19 Apr

Short Week Finishes with Netflix Q1 Beat

Zacks
·
18 Apr

Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Zacks
·
18 Apr

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2025-04-17

Reuters
·
18 Apr

Dow Down 262 Points On Losses In UnitedHealth, NVIDIA Corp. Stocks

Dow Jones
·
18 Apr

Amgen Inc. (AMGN): Among the Innovative Healthcare Stocks to Watch in 2025

Insider Monkey
·
17 Apr

UnitedHealth, Amgen Share Losses Lead Dow's Nearly 500-Point Drop

Dow Jones
·
17 Apr

Shares of Some Obesity Drug Developers Fall After Eli Lilly's Pill Leads to Weight Loss in Late-Stage Trial

THOMSON REUTERS
·
17 Apr

U.S.-Listed Shares of Novo Nordisk Down 7.9%, Viking Therapeutics Down 3.9%, Amgen Down 3.4%

THOMSON REUTERS
·
17 Apr

BUZZ-Eli Lilly jumps as pill leads to 7.9% weight loss in late-stage trial

Reuters
·
17 Apr

NVIDIA Corp., Amgen Share Losses Lead Dow's 200-Point Fall

Dow Jones
·
16 Apr

Eli Lilly Stock Down 8.2% in a Month: Should You Buy the Dip?

Zacks
·
16 Apr

Goldman Sachs Adjusts Price Target on Amgen to $400 From $408, Maintains Buy Rating

MT Newswires Live
·
15 Apr

Swiss stocks - Factors to watch on April 15

Reuters
·
15 Apr

Amgen Is Maintained at Neutral by UBS

Dow Jones
·
15 Apr

This Cholesterol Gene Medicine Could Work in 1 Shot. It Could Also Bring This Biotech Stock Back to Life. -- Barrons.com

Dow Jones
·
15 Apr

UBS Adjusts Amgen Price Target to $319 From $315, Maintains Neutral Rating

MT Newswires Live
·
14 Apr

Amgen Facing US Antitrust Lawsuit Filed by Sandoz

MT Newswires Live
·
14 Apr

Sandoz files antitrust litigation against Amgen regarding Enbrel

TIPRANKS
·
14 Apr

Sandoz Files Antitrust Lawsuit Against Amgen Over Enbrel Market Dominance

TIPRANKS
·
14 Apr